BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16110313)

  • 1. Targeted gene therapy for breast cancer with truncated Bid.
    Kazhdan I; Long L; Montellano R; Cavazos DA; Marciniak RA
    Cancer Gene Ther; 2006 Feb; 13(2):141-9. PubMed ID: 16110313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid promoters directed tBid gene expression to breast cancer cells by transcriptional targeting.
    Farokhimanesh S; Rahbarizadeh F; Rasaee MJ; Kamali A; Mashkani B
    Biotechnol Prog; 2010; 26(2):505-11. PubMed ID: 19918914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
    Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter.
    Berry NB; Cho YM; Harrington MA; Williams SD; Foley J; Nephew KP
    Gynecol Oncol; 2004 Mar; 92(3):896-904. PubMed ID: 14984958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells.
    Sadeqzadeh E; Rahbarizadeh F; Ahmadvand D; Rasaee MJ; Parhamifar L; Moghimi SM
    J Control Release; 2011 Nov; 156(1):85-91. PubMed ID: 21704663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
    Plumb JA; Bilsland A; Kakani R; Zhao J; Glasspool RM; Knox RJ; Evans TR; Keith WN
    Oncogene; 2001 Nov; 20(53):7797-803. PubMed ID: 11753658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific expression detected with the use of an expression vector driven by human telomerase reverse transcriptase gene promoter.
    Yin J; Fu P; Wang X; Jin G; Xiu R
    J Lab Clin Med; 2004 Dec; 144(6):302-6. PubMed ID: 15614252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.
    Day CP; Rau KM; Qiu L; Liu CW; Kuo HP; Xie X; Lopez-Berestein G; Hortobagyi GN; Hung MC
    Cancer Gene Ther; 2006 Jul; 13(7):706-19. PubMed ID: 16514421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.
    Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Barker S; Yamaoto M; Li F; Alvarez RD; Curiel DT
    Cancer Gene Ther; 2004 Apr; 11(4):256-62. PubMed ID: 15017380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of artificial chimerical gene regulatory elements specific for cancer gene therapy.
    Shin JH; Yi JK; Lee YJ; Kim AL; Park MA; Kim SH; Lee H; Kim CG
    Oncol Rep; 2003; 10(6):2063-9. PubMed ID: 14534744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
    J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cells.
    Edqvist A; Rebetz J; Järås M; Rydelius A; Skagerberg G; Salford LG; Widegren B; Fan X
    Mol Ther; 2006 Jul; 14(1):139-48. PubMed ID: 16584924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction of tumor cell-specific expression vector modulated by human telomerase reserse transcription gene core promoter].
    Li HM; Song TB; Yu YC; Huang HY; Zhang M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):96-8, 102. PubMed ID: 16388756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells.
    Shi CX; Long MA; Liu L; Graham FL; Gauldie J; Hitt MM
    Mol Ther; 2004 Oct; 10(4):758-67. PubMed ID: 15451460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-specific activation of the survivin promoter and its potential use in gene therapy.
    Chen JS; Liu JC; Shen L; Rau KM; Kuo HP; Li YM; Shi D; Lee YC; Chang KJ; Hung MC
    Cancer Gene Ther; 2004 Nov; 11(11):740-7. PubMed ID: 15359286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
    Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferentially enhanced gene expression from a synthetic human telomerase reverse transcriptase promoter in human cancer cells.
    Kim SJ; Lee HS; Shin JH; Kim CG; Jeong S; Park K; Choe H; Lee H
    Oncol Rep; 2006 Nov; 16(5):975-9. PubMed ID: 17016580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.